Advertisements


Sanofi Eczema Drug Dupixent Succeeds in Adolescents Study

Sanofi (SNY) announces positive results from a phase III study evaluating Dupixent for the treatment of moderate-to-severe atopic dermatiti.....»»

Category: personnelSource: nytMay 16th, 2018

Drug succeeds in arthritis study, Gilead stock jumps

A new drug meant to help rheumatoid arthritis achieved .....»»

Category: topSource: marketwatchSep 11th, 2018

Glaxo, J&J"s Dual Drug HIV Regimen Succeeds in Phase III Study

Glaxo (GSK) and Johnson and Johnson report positive top line results from a late-stage study of their injectable two-drug regimen for the treatment of HIV. GlaxoSmithKline’s GSK HIV drug subsidiary-ViiV H.....»»

Category: smallbizSource: nytAug 17th, 2018

Merck"s Keytruda Improves Survival in Head/Neck Cancer Study

Merck's (MRK) key cancer drug Keytruda succeeds as a monotherapy in phas.....»»

Category: worldSource: nytJul 25th, 2018

Pfizer"s Epilepsy Drug Lyrica Succeeds in Pediatric Study

Zacks.....»»

Category: topSource: redinewsMay 19th, 2018

Regeneron, Sanofi: FDA approves asthma indication for Dupixent

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall6 hr. 56 min. ago

The Daily Biotech Pulse: Eiger"s Lymphoedema Drug Study Fails, Roche"s Sales Rise

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 16) read more.....»»

Category: blogSource: benzingaOct 17th, 2018

Regeneron"s Dupixent Meets Goals in Nasal Polyps Studies

Regeneron's (REGN) atopic dermatitis drug, Dupixent meets goals in two late-stage studies for nasal polyps. Regeneron Pharmaceuticals, Inc. REGN and p.....»»

Category: worldSource: nytOct 17th, 2018

The Daily Biotech Pulse: Eiger"s Lymphoedema Drug Study Fails, Roche"s Sales Rise

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 16) Endo International PLC (NASDAQ: ENDP) Krys.....»»

Category: earningsSource: benzingaOct 17th, 2018

Roche Announces Positive Data on Breast Cancer Drug Kadcyla

Roche's (RHHBY) breast cancer drug Kadcyla, in a late-stage study in patients suffering from HER2-positive eBCmet, met its goal. Roche RHHBY announced encouraging results from a phase III st.....»»

Category: smallbizSource: nytOct 16th, 2018

Sanofi reports results from two Phase 3 trials evaluating Dupixent

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 16th, 2018

Regeneron, Sanofi announce Phse 3 Dupixent trials met all endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 16th, 2018

J&J"s Stelara Succeeds in Phase III Ulcerative Colitis Study

J&J's (JNJ) Stelara induces clinical remission and response in ulcerative colitis patients who had failed prior therapy, per data from a phase III study. Johnson & Johnson JNJ announce.....»»

Category: smallbizSource: nytOct 10th, 2018

Pain Therapeutics Granted $3.5M For Alzheimer"s Study, CEO Talks Micro-Cap Volatility

Pain Therapeutics, Inc. (NASDAQ: PTIE) is a micro-cap company that has developed several drug candidates, such as an abuse-resistant hydromorphone, an abuse-resistant hydrocodone and an antibody for metastatic melanoma. read more.....»»

Category: blogSource: benzingaOct 4th, 2018

Sanofi/Regeneron"s Cemiplimab Wins FDA Nod for Skin Cancer

Sanofi (SNY)/Regeneron's (REGN) anti- PD-1 drug cemiplimab wins FDA approval for a type.....»»

Category: personnelSource: nytOct 1st, 2018

Study suggests more older women may benefit from bone drugs

A bone-strengthening drug given by IV every 18 months greatly lowered the risk of fracture in certain older women, a large study found......»»

Category: topSource: foxnewsOct 1st, 2018

Is the possibility of a stroke in your genes?

A landmark international study of DNA samples from 520,000 people around the world, including 67,000 stroke patients, identified 22 new genetic risk factors for stroke.  It is the largest genetic study of stroke to date, and could lead to stroke drug.....»»

Category: topSource: bizjournalsOct 1st, 2018

Sanofi, Regeneron have skin-cancer drug approved

Sanofi and Regeneron Pharmaceuticals Inc. said late Friday the U.S. Food and Drug Admin.....»»

Category: topSource: marketwatchSep 28th, 2018

Amarin"s Stock Soars as Fish Oil Drug Lowers Heart Risks

Amarin (AMRN) shares soar on positive results from a cardiovascular outcomes study on Vascepa. Shares of Amarin Corporation p.....»»

Category: personnelSource: nytSep 27th, 2018

Achieve Life Sciences" stock rockets on positive study results for smoking cessation drug

Shares of Achieve Life Sciences Inc. shot up 31% to pace all premarket gainers Thursday, after the clinical-stage pharmaceutical company announced positive results from a study of its smoking cessation drug. Volume .....»»

Category: topSource: marketwatchSep 27th, 2018

Why Tilray Shares Are Getting Even Higher

Tilray continued its incredible rally with shares up massively on Tuesday after the U.S. Drug Enforcement Administration granted approval for the company to import a cannabinoid study drug for a........»»

Category: blogSource: 247wallstSep 18th, 2018